- Access clinical tools, resources, and patient materials
- Clinical Trials
- Discover what Enstilar® offers
- Explore the science behind Enstilar®
- News
- Product Review
- Test page list
- Biologics Masterclasses 2021
- Masterclasses 2023
- Secure Content
- General
- About ATEP
- GP pathways
- News & Articles
- Clinical Resources
- Edu & Videos
- Pre-biologic screening
- Transitioning patients from one biologic to another
- Managing a patient when efficacy starts to drop off
- The use of biologics in pregnancy
- How to manage drug holidays
- Patients wanting to travel whilst being on a biologic
- Using biologics with patients who have a history of malignancy
- Biologic agents in Dermatology
- Systemic Treatments
- Topical Therapies in Psoriasis
- Introduction to Scoring Systems
- Elements of successful PBS Initial Applications
- Elements of successful continuation applications, clinical tools and tips and patient education
- Biosimilars
- General PBS Forms
- Alopecia areata (AA)
- Atopic dermatitis (AD)
- Chronic spontaneous urticaria (CSU)
- Drugs Quick Link
- Hidradenitis suppurativa (HS)
- Psoriasis
- Member
- Privacy
- Account
- Advanced targeted therapies masterclass series Sep – Nov 2022
- Ask the Experts
- Australasian Psoriasis Registry – APR
- Biologics and advanced targeted therapies masterclass series Sep – Nov 2021
- Biologics Masterclass for Registrars
- Care Plans
- Chronic Spontaneous Urticaria (CSU) – Omalizumab
- Clinical Information
- Clinical Resources
- Dermatology Scientific Webcast, April 2020
- DLQI
- Drugs
- EARP/DLQI
- Enbrel
- FAQ’s
- Hidradentitis Suppurativa (HS)
- Hot Topics 1 – When to switch and what to choose
- Humira – HS
- Inflammation & Skin Malignancy
- Inflectra
- Letter templates
- Links
- Managing Psoriasis in Obese Patients
- Masterclass for Nurses Sep – Oct 2020
- My Details
- News
- Psoriasis Research Review, Issue 31
- Psoriasis Research Review, Issue 32
- Psoriasis Research Review, Issue 33
- Psoriasis Research Review, Issue 34
- Psoriasis Research Review, Issue 35
- Psoriasis Research Review, Issue 36
- Response to question
- Systemic Treatments
- Thank You
- Videos
- Visit Scheduler (CSU)
- Visit Scheduler (HS)
- Visit Schedulers
- What is the impact of half-life on biologic efficacy and safety
- General
- Z_Pharma Abbvie
- Z_BMS
- Z_Pharma Celgene
- Welcome to ATEP
- Z_Pharma Janssen
- Z_Pharma Lilly
- General Content
- test
- Unauthorised
- Urti
- Z_Amgen
- Z_Leo
- Z_Pharma Novartis
- Z_Pharma_Sanofi
- Z_Sun Pharma ANZ
- Z_UCB
- Lilly – Lebrikizumab
- Galderma – Abrocitinib
- Atopic Dermatitis Scoring Guidance Video
- Galderma – Nemolizumab
- Test Page
- Pfizer- Abrocitinib – Cibinqo
- Masterclasses